Inventiva S.A. (IVA) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-31 16:22:03 ET
Inventiva S.A. (IVA) Q4 2025 Earnings Call March 31, 2026 8:00 AM EDT
Company Participants
David Nikodem
Andrew Obenshain - CEO & Director
Jason Campagna - President of Research and Development & Chief Medical Officer
Jean Volatier - Deputy GM & CFO
...
Read the full article on Seeking Alpha
For further details see:
Inventiva S.A. (IVA) Q4 2025 Earnings Call Transcript
Inventiva S.A.
NASDAQ: IVA
IVA Trading
-5.79% G/L:
$4.07 Last:
342,792 Volume:
$4.20 Open:
IVA Latest News
IVA Stock Data
$596,933,320
80,739,058
N/A
18
N/A
Biotechnology & Life Sciences
Healthcare
FR
Daix
